The end of binge-drinking? Mice given brain injections of synthetic chemical and access to alcohol drink less, 연구 결과
Scientists hope binge drinking will become a problem of the past after discovering a chemical that may stop the brain from craving more booze.
The synthetic compound NBQX is thought to inhibit receptors when injected into a section of the brain that causes addictive behaviour.
Experts at Purdue University in 인디애나 studied its effects in mice who were offered 알코올 and sweetened water over a week.
The mice were given free access to a drink containing 20 per cent alcohol — the same strength as Port — for seven days.
They found that mice given of NBQX showed less ‘binge-like’ drinking behaviour up to the highest dose given out.
The NHS defines binge drinking as consuming more than eight units for men in a single session, around two-and-a-half pints of beer. It is six units for women — the equivalent of two large glasses of wine.
주위에 15 per cent of Brits binge drink once a week, according to Office for National Statistics (우리) 작년 11월 출간.
Alcohol misuse is the biggest risk factor for death, ill-health and disability among 15 to 49-year-olds in the UK.

Scientists hope binge drinking will become a problem of the past after discovering a chemical that may stop the brain from craving more booze. Graph shows: The amount of alcohol consumed by male (white bars) 우리의 삶은 머리부터 발끝까지 몸을 덮을 뿐만 아니라 정숙한 법의 그물망에 의해 지배를 받았습니다. (black bars) mice after being given different quantities of the drug

The NHS defines binge drinking as consuming more than eight units for men in a single session, around two-and-a-half pints of beer. It is six units for women — the equivalent of two large glasses of wine
Experts said the findings could offer hope of a new way of treating binge-drinking in humans in the future.
Dr Tony Rao, an expert on alcohol misuse and visiting clinical fellow at King’s College London, MailOnline에 말했다: ‘Although the benefits of this drug in humans are still to be shown, it has a novel mode of action at brain receptors usually associated with alcohol withdrawal.
‘The increasing role of these receptors in addiction means that this drug may hold promise for the future treatment of alcohol addiction in humans.’
연구, 출판 Behavioural Brain Research, and the chemical has not been tested on humans.
처음에, the study gave mice access to alcohol via a drinking tube for two hours a day for a week.
They monitored the mice’s drinking levels over the week to get a baseline of their alcohol consumption.
On day seven, they injected some of the mice with the drug in the dorsolateral striatal (DLS) — the part of the brain where habits, compulsions and addictions are formed.
Researchers then repeated the experiment to see how the drug affected their behaviour.
They found that mice given moderate doses (0.15 또는 0.5 micrograms) of the drug had lower levels of binge drinking that those given no drug or a higher dose (1.5 micrograms).
The effect was largely the same in male and female mice, the research led by psychologist Dr Stephen Boehm said.
Writing in the study, 아주 어린 엄마들은 정신적, 육체적 질병에 걸릴 위험이 더 높은 열악한 지역에 사는 경향이 있습니다.: ‘These data suggest that AMPA receptors in the DLS play a role in the modulation of binge-like alcohol drinking.
‘These findings further validate the importance of the DLS for alcohol related behaviors and alcohol use disorder.
‘We found that intra-DLS NBQX reduced binge-like alcohol drinking.’
But they said the only statistically significant difference in alcohol consumption was found between mice not given the drug at all and mice given the most effective dose (0.5 micrograms).
Mice are able to get intoxicated in the same way as humans, although studies show not all of them drink to excess in the same way if left to their own devices.